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O B J E C T I V E S We sought to assess whether hyperinsulinemia is associated with percentage lipid
and coronary plaque burden in nondiabetic patients with acute coronary syndromes (ACS).
B A C KG ROUND Hyperinsulinemia carries an increased risk of cardiovascular disease even in
pre-diabetic patients, but the precise mechanisms of its effects remain unclear.
METHOD S Nonculprit coronary lesions associated with mild-to-moderate stenosis in 82 nondia-
betic patients with ACS were examined by integrated backscatter intravascular ultrasound (IB-IVUS),
using a 40-MHz intravascular catheter. Conventional IVUS and IB-IVUS measurements from the worst
10-mm segment (1-mm intervals) were calculated. All patients underwent a 75-g oral glucose tolerance
test (OGTT) to calculate the area under the insulin concentration-time curve (AUC insulin) from 0 to 120 min.
R E S U L T S Patients in the high tertile of AUC insulin had a signiﬁcantly greater percentage lipid area
and absolute lipid volume than did patients in the intermediate and low tertiles (tertile 3 vs. tertile 2 vs.
tertile 1; 37.6  16.6% vs. 25.8  11.9% vs. 27.5  14.7%, p  0.01 by analysis of variance [ANOVA], and
29.9  22.6 mm3 vs. 15.3  12.6 mm3 vs. 17.7  12.7 mm3, p  0.01 by ANOVA, respectively) and a
smaller percentage ﬁbrosis area (55.0  11.5% vs. 61.7  9.4% vs. 60.7  9.4%, p  0.03 by ANOVA).
Multiple regression analysis showed that the high tertile of AUC insulin was independently associated
with an increased percentage lipid area (p  0.05). On conventional IVUS analysis, external elastic
membrane cross-sectional area was signiﬁcantly increased with greater plaque volume in patients in the
high tertile of AUC insulin (both p  0.05 by ANOVA).
CONC L U S I O N S Hyperinsulinemia is associated with an increased lipid content and a greater
plaque volume of nonculprit intermediate lesions in nondiabetic patients with ACS, suggesting that
plaque vulnerability is increased in this subgroup of patients. (J Am Coll Cardiol Img 2011;4:392–401)
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393iabetes mellitus (DM) is a well-established
risk factor for coronary artery disease
(CAD). Coronary atherosclerosis is ac-
celerated, not only in diabetic patients,
but also in pre-diabetic patients with abnormal
glucose metabolism, as compared with individu-
als with normal glucose metabolism (1). In fact, a
large cohort study has shown that abnormal
glucose metabolism before overt DM is associ-
ated with a 50% to 60% higher risk of mortality
(2). A better understanding of the mechanisms
linking abnormal glucose metabolism to CAD is
needed to develop new strategies to prevent
premature mortality from cardiovascular disease
in patients with milder forms of abnormal glucose
metabolism.
Hyperinsulinemia, a marker of insulin resistance,
is related to impaired glucose tolerance (IGT) and
DM (3). Accumulating evidence suggests that in-
sulin directly promotes atherogenesis (4). The Hel-
sinki Policemen Study showed that hyperinsulin-
emia without DM predicted the risk of CAD-
related events during 22 years of follow-up (5).
Patients with hyperinsulinemia may thus have
increased plaque vulnerability even before the
onset of DM. However, few studies have directly
examined the relevance of hyperinsulinemia to
plaque vulnerability.
Prior studies have indicated that the degree of
stenosis caused by culprit lesions in acute coronary
syndromes (ACS) is not necessarily severe on cor-
onary angiography weeks to months before the
onset of symptoms (6). The disruption of vulnerable
plaque associated with mild-to-moderate angio-
graphic stenosis and subsequent thrombosis is thus
thought to contribute to the onset of ACS (7).
Plaque disruption and acute occlusion occur at sites
of vulnerable plaque with a high lipid content
covered by a thin fibrous cap (8,9).
Recently, Kawasaki et al. (10) have developed a
technique for integrated backscatter intravascular
ultrasound (IB-IVUS) that can identify different
components of atherosclerotic plaque in human
coronary arteries in vivo. This study tested the
hypothesis that hyperinsulinemia is associated with
an increased lipid component of atherosclerotic
plaques, which may heighten plaque vulnerability.
The relation between hyperinsulinemia and the
tissue characteristics of nonculprit intermediate cor-
onary plaques on IB-IVUS was examined in non-
diabetic patients with ACS.M E T H O D S
Subjects. This study was a prospectively planned
observational study of nonculprit coronary plaques
in patients with ACS. Consecutive patients with
ACS who underwent percutaneous coronary inter-
vention (PCI) with IVUS guidance at the Yoko-
hama City University Medical Center were
screened for eligibility. Patients with a previous
diagnosis of DM and an HbA1c level of more than
6.5% were excluded because it is difficult to evaluate
the insulin response to a glucose load in such
patients owing to impaired insulin secretion (11). A
total of 112 patients in stable condition underwent
75-g oral glucose tolerance tests (OGTT)
before hospital discharge. We excluded 25
patients in whom DM was diagnosed on
OGTT and 5 patients for whom IB-IVUS
data were unavailable. Finally, 82 lesions
with mild-to-moderate stenosis in 82
nondiabetic patients with ACS were stud-
ied. The study protocol was approved by
the ethics committee of Yokohama City
University Medical Center. We obtained
written informed consent from all partic-
ipants before initial coronary angiography.
Cardiovascular diagnosis. ACS was defined
as unstable angina, ST-segment elevation
myocardial infarction, or non–ST-segment
elevation myocardial infarction. Unstable
angina was defined as new-onset severe an-
gina, accelerated angina, or angina at rest
without a significant rise in cardiac-specific
troponin T levels. New-onset angina was
defined as angina in which 2 months had
lapsed from the date of initial symptoms.
ccelerated angina was defined as angina in
hich symptoms were more frequent, more
evere, longer, or precipitated by distinctly
ess exertion than previously, while the pa-
ient was in stable condition. ST-segment elevation
yocardial infarction was defined as the continuous
resence of chest symptoms for more than 30 min,
T-segment elevation of 0.1 mV in 2 limb leads or
0.2 mV in 2 contiguous precordial leads, and a rise
n cardiac-specific troponin T levels. Non–ST-
egment elevation myocardial infarction was defined
s chest pain and a rise in cardiac-specific troponin T
evels without new ST-segment elevation (12).
Assessment of glucose metabolism and lipid proﬁles.
Patients without a prior diagnosis of DM under-
went a 75-g OGTT while they were in stable
A B B
A N D
ACS
syndr
ANOV
AUC
CAD
CSA
DM
EEM
memb
HOMA
assess
IB-IVU
backs
ultras
IGT
tolera
IRI
IVUS
OGTT
test
PCI
interv
PMcondition at least 4 days after admission (13).R E V I A T I O N S
A C R O N YM S
acute coronary
ome(s)
A analysis of variance
area under the curve
coronary artery disease
cross-sectional area
diabetes mellitus
external elastic
rane
-IR homeostasis model
ment of insulin resistance
S integrated
catter intravascular
ound
impaired glucose
nce
immunoreactive insulin
 intravascular ultrasound
 oral glucose tolerance
percutaneous coronary
entionAfter
P
4
n
r
t
A
i
c
f
p
C
s
t
v
a
f
c
v
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 4 , 2 0 1 1
A P R I L 2 0 1 1 : 3 9 2 – 4 0 1
Mitsuhashi et al.
Hyperinsulinemia and Plaque Vulnerability
394an overnight fast, venous blood samples for the
measurement of plasma glucose levels and immu-
noreactive insulin (IRI) levels were taken at base-
line, 60 min, and 120 min after the glucose load.
Glucose metabolism was then classified on the basis
of the results of OGTT as follows: IGT  fasting
blood glucose level 126 mg/dl and 120-min
post-load blood glucose level 140 mg/dl, but
200 mg/dl; DM  fasting blood glucose level
126 mg/dl or 120-min post-load blood glucose
200 mg/dl.
The area under the insulin concentration-time
curve (AUC insulin) was calculated from the IRI
levels at baseline, 60 min, and 120 min with the use
of the trapezoid rule (5). The AUC insulin was used
as a composite variable reflecting IRI levels. Ho-
meostasis model assessment of insulin resistance
(HOMA-IR) was calculated by the following for-
mula: (fasting blood glucose level  fasting IRI
level)/405.
IVUS and IB-IVUS examinations. Immediately after
CI, IVUS examinations were performed using a
0-MHz mechanical scanning monorail intracoro-
ary ultrasound catheter (Boston Scientific Corpo-
ation, Natick, Massachusetts). All IVUS examina-
ions were performed in the following manner.
fter the intracoronary administration of 2 to 3 mg of
sosorbide dinitrate, the catheter was positioned suffi-
iently distal to the site of PCI. Pullback was per-
ormed automatically at 0.5 mm/s. A personal com-
uter equipped with custom software (IB-IVUS, YD
o., Nara, Japan) was connected to the IVUS imaging
ystem to obtain radiofrequency signal output, signal
rigger output, and video image output. The IB
alues for each tissue component were calculated
s the average power, using a fast Fourier trans-
ormation, measured in decibels, of the frequency
omponent of backscattered signals from a small
olume of tissue (10).
Analysis of conventional IVUS and IB-IVUS data. The
IVUS images for the entire target vessel post-PCI
were reviewed, and target plaque was determined.
The target plaque had to be an intermediate
lesion with no more than 50% luminal narrowing
on angiography and no previous PCI. All ana-
lyzed plaques were located in the treated vessel
and had to be situated at least 5 mm from the
culprit lesion. Each plaque was measured by
conventional IVUS and IB-IVUS at 1-mm inter-
vals throughout the most diseased (containing the
greatest plaque volume) 10-mm segment. The
target plaque was selected, and the conventional
grayscale IVUS and IB-IVUS data were analyzed fby an investigator who was blinded to the pa-
tients’ characteristics.
Conventional IVUS image analysis was con-
ducted using commercially available software (Echo
Plaque, Indec Systems, Mountain View, Califor-
nia). Quantitative analysis was performed according
to the American College of Cardiology Clinical
Expert Consensus Document on IVUS (14). The
cross-sectional area (CSA) measurements included
the lumen and the external elastic membrane
(EEM) CSA. The luminal-intimal border was
traced manually to determine the lumen CSA.
EEM CSA was measured by tracing the external
edge of the media-adventitia border. Plaque plus
media (PM) CSA was calculated as the EEM
CSA minus the lumen CSA. Remodeling index
was calculated as the minimum lumen area site
EEM CSA divided by the average of the proximal
and distal reference site EEM CSA, as described
previously (15). The EEM, lumen, and PM
volumes were calculated by Simpson method for the
integration of 1-mm-thick disks for the 10 serial
CSAs (16).
Color-coded maps based on IB values were
constructed for consecutive IVUS image slices of
the target plaque. Because the media of the coro-
nary arteries always presents with a low echoic
band, potentially identified as “lipid” by the algo-
rithm currently used for IB-IVUS, the luminal-
intimal border and intimal-medial border were
traced manually. The percentages of each plaque
component (lipid, fibrosis, dense fibrosis, and cal-
cification) were automatically computed by the
IB-IVUS system after exact manual tracing. The
absolute value of each plaque component was cal-
culated (sum of each plaque component in each
CSA at 1-mm intervals for the 10-mm length), and
the average values of each plaque component were
expressed relative to the total volume. Cross-
sectional IB-IVUS analysis was also performed at
the minimal lumen site.
Whole-vessel IB-IVUS analysis prior to PCI. We evalu-
ated plaque components for all available frames
(mean length of 52 mm) in the target vessel prior to
PCI by IB-IVUS analysis at 1-mm intervals. We
excluded 6 patients in whom pre-intervention
IVUS could not be performed because the IVUS
catheter could not cross the lesion. We also ex-
cluded 12 patients for whom adequate IB-IVUS
data were unavailable. Therefore, IB-IVUS data
prior to PCI qualified for evaluation in 64 patients.
Statistical analysis. Statistical analysis was per-
ormed with StatView 5.0 software (SAS Institute,
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395Cary, North Carolina). Qualitative data are pre-
sented as numbers (%). Normally distributed, con-
tinuous variables are expressed as mean  SD, and
continuous variables with skewed distributions
(triglycerides and C-reactive protein) are expressed
as median values (interquartile range). Categorical
variables were compared by the chi-square test.
Continuous clinical and IVUS variables among the
3 groups were compared by analysis of variance
(ANOVA), with pairwise post hoc comparisons
adjusted by the Bonferroni method. For continuous
variables with skewed distributions, the Kruskal-
Wallis test was used to examine differences in
median values, with pairwise post hoc comparisons
by the Mann-Whitney U test with the Bonferroni
adjustment. Correlations of plaque contents, as
assessed by IB-IVUS, with the high tertile of AUC
insulin and clinical and laboratory variables were
evaluated by simple regression analysis. Multiple
linear regression analysis was used to determine the
best predictors of the percentage lipid area. Loga-
rithms (base 2) of triglycerides and C-reactive
protein were used in all the regression analyses to
account for the skewed distributions of these vari-
ables. Univariate predictors of percentage lipid area
with p values of 0.2 were entered into the multi-
variate model. Independent predictors and their
regression coefficients were calculated. Differences
with p values of 0.05 were considered statistically
significant, except when employing the Bonferroni
adjustment. In the analysis with Bonferroni adjust-
ment, p values of 0.0167 were considered
ignificant.
R E S U L T S
Subjects and baseline characteristics. The mean age
f the patients was 64  12 years. Seventy-nine
ercent of the study group were men, 45% had a
istory of hypertension, and 55% were current
mokers. At admission, statins were being used by
8% of the patients. The criteria for IGT was met
n 65%. The AUC insulin, calculated from the
esults of a 75-g OGTT, ranged from 1,998 to
8,080 IU/l  min in this patient cohort. Unstable
ngina was diagnosed in 15% of the patients,
on–ST-segment elevation myocardial infarction in
4%, and ST-segment elevation myocardial infarc-
ion in 61%. The prevalence of IGT was similar
mong the 3 groups (64% vs. 65% vs. 67%, p 
.98). The AUC insulin tended to be higher in
atients with unstable angina than in those with
on–ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction
10,087  6,958 IU/l  min vs. 8,071  3,568
U/l  min vs. 7,182  3,496 IU/l  min, p 
.097 by ANOVA).
The patients were divided into 3 groups accord-
ng to the tertile of AUC insulin at baseline: tertile
(low tertile), 27 patients with AUC insulin of
5,300 IU/l  min; tertile 2 (intermediate tertile),
7 patients with AUC insulin of 5,300 to 9,000
U/l  min; and tertile 3 (high tertile), 28 patients
ith AUC insulin of  9,000 IU/l  min. The
aseline characteristics of the subjects are shown in
able 1. Body mass index and waist circumference
ere significantly greater in patients in the high
ertile of AUC insulin than those in the interme-
iate or low tertiles. Lipid profiles and the preva-
ence of hypertension, current smokers, and statin
se at admission did not differ among the tertiles.
linical presentation, the proportions of patients
ith multivessel disease and stent implantation, and
arget plaque locations were also similar. As ex-
ected, fasting IRI levels were significantly higher
n the high tertile of AUC insulin than in the other
ertiles. Serum triglycerides and the prevalence of
GT were significantly higher in the high tertile
han in the low tertile.
Quantitative measures of conventional and IB-IVUS.
Table 2 shows the results of conventional grayscale
IVUS analyses. The EEM, lumen, and PM
volumes were greater in the high tertile of AUC
insulin than in the intermediate and low tertiles
(p  0.05 by ANOVA). The remodeling index and
the proportion of target plaques proximal to the
PCI site were similar in the 3 groups.
On IB-IVUS analysis, patients in the high
tertile of AUC insulin had a significantly greater
percentage lipid area than those in the interme-
diate and low tertiles (tertile 3 vs. tertile 2 vs.
tertile 1; 37.6  16.6% vs. 25.8  11.9% vs. 27.5 
14.7%, p  0.01 by ANOVA) (Fig. 1A), as well as
a smaller percentage fibrosis area (55.0  11.5%
vs. 61.7  9.4% vs. 60.7  8.9%, p  0.03 by
ANOVA) (Fig. 1B) and percentage dense fibrosis
area (5.5 5.0% vs. 9.4 5.1% vs. 8.7 6.6%, p
0.02 by ANOVA) (Fig. 1C). The percentage
alcification area was similar in the 3 groups (p 
.14 by ANOVA) (Fig. 1D). The absolute lipid
olume was significantly greater in the high
ertile of AUC insulin than in the intermediate
nd low tertiles (tertile 3 vs. tertile 2 vs. tertile 1:
9.9  22.5 mm3 vs. 15.3  12.6 mm3 vs. 17.7 
2.7 mm3, p  0.01 by ANOVA) (Fig. 2A). The
bsolute fibrosis volume, dense fibrosis volume,
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396and calcification volume were similar among the 3
groups. At the minimal lumen site, similar results
were obtained (tertile 3 vs. tertile 2 vs. tertile 1: 3.4 
2.9 mm2 vs. 1.7  1.6 mm2 vs. 2.1  1.5 mm2, p 
0.01 by ANOVA) (Fig. 2B). Figure 3 shows repre-
Table 1. Baseline Clinical Characteristics of Patients by Tertiles
Tertile 1 (n  27)
Age, yrs 67 11
Male sex 21 (78)
Target plaque location
Left anterior descending 11 (41)
Left circumﬂex 0 (0)
Right 16 (59)
Clinical presentation
Unstable angina 3 (11)
Non–ST-segment elevation MI 6 (22)
ST-segment elevation MI 18 (67)
Stent implantation 26 (96)
BMS 19 (70)
DES 7 (26)
Previous PCI 1 (4)
Multivessel disease 12 (44)
Body mass index, kg/m2 22.4 2.9
Waist circumference, cm 84 7
Hypertension 9 (33)
Current smoker 15 (56)
Blood lipid levels, mg/dl
LDL cholesterol 134 30
HDL cholesterol 47 9
Triglycerides 92 (55–126)
Statin use at admission 5 (19)
hs-CRP, mg/dl 0.163 (0.062–0.996)
IGT 13 (48)
HemoglobinA1c, % 5.2 0.4
Fasting blood glucose, mg/dl 98 7
Fasting IRI, IU/l 4.9 2.0
AUC insulin, IU/l  min 3,876 889
Values are mean  SD or n (%). p  chi-square test, analysis of variance, or Kru
to 75th percentiles) or numbers of patients (percentages). *p  0.0167 by Bonf
and tertile 2).
ACS  acute coronary syndrome; AUC  area under curve; BMS  bare-m
high-sensitivity C-reactive protein; IGT  impaired glucose tolerance; IRI  imm
intervention; MI  myocardial infarction.
Table 2. Data for Conventional Intravascular Ultrasound
Tertile 1 (n  27)
EEM volume, mm3 134 42
Lumen volume, mm3 74 30
PM volume, mm3 59 27
Remodeling index 0.94 0.12
Proximal to the PCI site, % 78
p  analysis of variance, values are means  standard deviations. *p  0.0167
EEM  external elastic membrane; PM  plaque plus media; PCI  percutaneousentative conventional IVUS images and IB-IVUS
color-coded maps of a nonculprit coronary plaque in a
patient belonging to the high tertile of AUC insulin
and those in a patient belonging to the low tertile of
AUC insulin.
UC Insulin
ertile 2 (n  27) Tertile 3 (n  28) p Value
63 12 60 12 0.10
19 (70) 25 (89) 0.22
0.15
15 (56) 14 (50)
3 (11) 4 (14)
9 (33) 10 (36)
0.41
3 (11) 6 (21)
5 (19) 9 (33)
19 (70) 13 (46)
25 (93) 28 (100) 0.34
19 (70) 21 (75) 0.91
6 (23) 7 (25) 0.95
0 (0) 2 (7) 0.38
10 (37) 13 (46) 0.77
23.6 3.6 26.4 3.9† 0.01
85 9 94 11† 0.01
13 (48) 15 (54) 0.30
17 (63) 13 (46) 0.47
149 39 140 26 0.20
52 15 48 14 0.26
101 (57–199) 174 (133–234)* 0.01
4 (15) 6 (21) 0.82
.187 (0.093–0.355) 0.130 (0.091–0.585) 0.95
17 (63) 23 (82) 0.03
5.4 0.4 5.3 0.3 0.35
101 8 103 7 0.07
6.3 1.7 10.8 4.7† 0.01
7,068 1,244* 12,360 3,769† 0.01
Wallis test among the 3 tertiles; values are mean  SD or median values (25th
i adjustment (vs. tertile 1); †p  0.0167 by Bonferroni adjustment (vs. tertile 1
stent; DES  drug-eluting stent; HDL  high-density lipoprotein; hs-CRP 
reactive insulin; LDL  low-density lipoprotein; PCI  percutaneous coronary
rtile 2 (n  27) Tertile 3 (n  28) p Value
129 42 166 50* 0.05
76 24 93 34 0.05
56 25 73 28 0.05
0.99 0.17 0.96 0.12 0.45
59 75 0.28
Bonferroni adjustment (vs. tertile 1 and tertile 2).of A
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397Simple and multiple regression analysis for percentage
lipid area as the dependent variable. The high tertile
of AUC insulin was used as a variable for simple
and multiple regression analyses for percentage lipid
area because the high tertile of AUC insulin had
significantly increased percentage lipid area com-
pared with intermediate and low tertiles (p  0.004
and p  0.01, respectively, by the Bonferroni
adjustment). On simple regression analysis, the
0
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% Lipid AreaA
ns
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Figure 1. Relations Between AUC Insulin and Each Relative Plaq
Nonculprit plaques in patients belonging to the high tertile of area
age lipid area (A) as compared with those in patients belonging to
37.6  16.6% vs. 25.8  11.9% vs. 27.5  14.7%, p  0.007 by ana
(B) (55.0  11.5% vs. 61.7  9.4% vs. 60.7  8.9%, p  0.03 by AN
5.1% vs. 8.7  6.6%, p  0.02 by ANOVA). The percentage calciﬁca
Figure 2. Relations Between AUC Insulin and Absolute Lipid Vo
Nonculprit plaques in patients belonging to the high tertile of area
and lipid area at minimal lumen site as compared with those in pa
tile 2 vs. tertile 1: 29.9  22.5 mm3 vs. 15.3  12.6 mm3 vs. 17.7 
2 2 21.5 mm vs. 1.7  1.6 mm vs. 2.1  1.5 mm , p  0.006 by ANOVA [Bhigh tertile of AUC insulin (r  0.34, p  0.01),
younger age (r  0.25, p  0.03), male sex (r 
0.33, p 0.01), and the presence of IGT (r 0.27,
p  0.01) correlated with a greater percentage
lipid area (Table 3). Multiple regression analysis
showed that the high tertile of AUC insulin and
the prevalence of IGT were independently asso-
ciated with an increased percentage lipid area
(Table 3).
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er the curve (AUC) insulin had a signiﬁcantly increased percent-
intermediate and low tertiles (tertile 3 vs. tertile 2 vs. tertile 1:
of variance [ANOVA]) and a decreased percentage ﬁbrosis area
) and percentage dense ﬁbrosis area (C) (5.5  5.0% vs. 9.4 
area (D) did not differ signiﬁcantly among the 3 groups.
e and Lipid Area at Minimal Lumen Site
er the curve (AUC) insulin had an increased absolute lipid volume
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398Relations between IGT and HOMA-IR and plaque
components. IGT is reported to be associated with
hyperinsulinemia (3). Therefore, we evaluated the
Figure 3. Representative Images of Conventional IVUS and IB-IV
The percentage lipid area, percentage ﬁbrosis area, and percentage
1.8%, respectively, in a patient belonging to the high tertile of area
percentage lipid area, percentage ﬁbrosis area, and percentage den
patient belonging to the low tertile of AUC insulin (AUC insulin,
yellow  dense ﬁbrosis area, red  calciﬁcation area. IB-IVUS 
ultiple Regression Analysis With % Lipid Area
riable
Simple Regression Multiple Regression
Regression
Coefﬁcient p Value
Regression
Coefﬁcient p Value
0.33 0.03 0.18 0.27
12.43 0.01 6.72 0.13
0.53 0.23
3.53 0.46
tion MI 3.53 0.37
MI 0.88 0.80
0.12 0.97
4.89 0.15 3.19 0.38
0.04 0.42
0.23 0.07 0.13 0.34
2.33 0.19 2.13 0.24
2.52 0.57
0.87 0.24
8.69 0.01 6.60 0.04
0.43 0.06 0.40 0.06
insulin 10.95 0.01 7.91 0.031.relation between IGT and percentage lipid area.
Patients with IGT had a significantly greater per-
centage lipid area as compared with those with
normal glucose tolerance (IGT vs. normal glucose
tolerance: 33.4  15.6% vs. 24.7  13.3%, p 
0.01) (Fig. 4).
In addition, we evaluated the association be-
tween HOMA-IR and plaque components, since
HOMA-IR is a simple method for assessing
insulin resistance (17). We divided the patients
into the 3 tertiles according to the HOMA-IR
levels: tertile 1, 27 patients with HOMA-IR of
1.23; tertile 2, 27 patients with HOMA-IR of
1.23 to 1.93; and tertile 3, 28 patients with
HOMA-IR of 1.93. There were no significant
differences in percentage lipid area among the 3
tertiles (p  0.20 by ANOVA). On simple
regression analysis, the high tertile of HOMA-IR
showed a trend toward an increased percentage
lipid area (r  0.19, p  0.09).
Subgroup analysis of the whole target vessel prior to
PCI. In 64 patients in whom whole target vessels
rior to PCI were analyzed, patients with the high
ertile of AUC insulin had the highest percentage
ipid area (tertile 3 vs. tertile 2 vs. tertile 1: 38.7 
3.5% vs. 30.7  14.2% vs. 26.1  9.3%, p  0.01
Color-Coded Maps of Coronary Artery Plaques
se ﬁbrosis area of coronary artery plaque were 69.8%, 27.0%, and
er the curve (AUC) insulin (AUC insulin, 13,290; top panels). The
brosis area were 25.9%, 67.0%, and 5.7%, respectively, in a
6; bottom panels). Blue  lipid area, green  ﬁbrosis area,
grated backscatter intravascular ultrasound.US
den
und
se ﬁ
4,74Table 3. Simple and M
as the Dependent Va
Variable
Age
Male
Body mass index
Unstable angina
Non–ST-segment eleva
ST-segment elevation
Hypertension
Current smoker
LDL cholesterol
HDL cholesterol
Triglycerides
Statin use at admission
hs-CRP
IGT
Fasting blood glucose
The high tertile of AUCby ANOVA) (Fig. 5).
ce (NGT).
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Our IB-IVUS study assessed the impact of hyper-
insulinemia, expressed as the AUC insulin during a
75-g OGTT, on the tissue characteristics of coro-
nary plaques associated with angiographically mild-
to-moderate coronary lesions. We found that hy-
perinsulinemia was related to a significantly
increased lipid content and a greater plaque volume
of nonculprit intermediate lesions in nondiabetic
patients with ACS. These results provide important
insight into the relation between hyperinsulinemia
and plaque stability.
It has been reported that disruption of vulnerable
plaques and subsequent thrombus formation are the
most frequent causes of ACS (7). Lipid incorpora-
tion into the arterial wall is the key event in the
initiation of atherosclerosis, and the formation of a
soft lipid core is an important determinant of
spontaneous plaque rupture (18). Necropsy studies
have suggested that the presence of a large lipid-
rich core is associated with a high risk of ACS after
spontaneous or mechanically induced rupture be-
cause of the thrombogenicity of the lipid content
(19). Previous conventional IVUS studies have
shown that large eccentric plaques containing an
echolucent zone can have an increased risk of
instability even if the lumen area is preserved at the
time of initial study, indicating that tissue charac-
teristics have a great impact on coronary plaque
vulnerability (8). Recent preliminary in vitro studies
have shown that IB values reflect the structural and
biochemical compositions of atherosclerotic le-
sions and can differentiate fibrofatty, fatty, and
calcified lesions of arterial walls (20). Okubo et
al. (21) used IB values to analyze lipid-rich,
fibrotic, and fibrocalcific coronary plaque compo-
nents and obtained high predictive accuracies of
90%, 93%, and 96%, respectively, as compared
with the corresponding histological images.
Therefore, IB-IVUS is a well-validated and es-
tablished method that provides accurate informa-
tion on plaque components.
DM is well recognized to be a major risk factor
for CAD, and hyperinsulinemia is an indicator of
insulin resistance that precedes the development of
DM (3). Several studies have demonstrated that
hyperinsulinemia is associated with an increased
risk of CAD events in pre-diabetic patients
(5,22,23). These findings suggest that macrovascu-
lar disease starts before the development of DM in
patients with hyperinsulinemia. In the present
study, hyperinsulinemia was significantly related toan increased plaque lipid content in nondiabetic
patients with ACS. Our results are supported by the
findings of previous IVUS tissue characterization
studies showing that plaque vulnerability is in-
creased in patients with DM as well as those with
insulin resistance. Recently published virtual histol-
ogy IVUS studies have reported that the prevalence
of a necrotic core is significantly higher in patients
with DM, especially in those with a longer duration
of DM (24), than in patients without DM (25,26).
Marso et al. (27) have shown that low adiponectin
levels, which correlate with high insulin resistance,
are associated with increased plaque volume and
lipid-rich plaque in nondiabetic coronary arteries.
Figure 4. Relation Between IGT and Percentage Lipid Area
Patients with impaired glucose tolerance (IGT) showed a signiﬁcant
age lipid area as compared with those with normal glucose toleran
Figure 5. Relation Between AUC Insulin and Percentage Lipid A
the Whole Target Vessel Prior to PCI
In the whole target vessel prior to percutaneous coronary intervent
percentage lipid area was highest in the high tertile of AUC insulin
pared with the intermediate and low tertiles (tertile 3 vs. tertile 2 v
1: 38.7  13.5% vs. 30.7  14.2% vs. 26.1  9.3%, p  0.01 by ANincrease in percent-rea in
ion (PCI),
as com-
s. tertile
OVA).Abbreviations as in Figures 1 and 3.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 4 , 2 0 1 1
A P R I L 2 0 1 1 : 3 9 2 – 4 0 1
Mitsuhashi et al.
Hyperinsulinemia and Plaque Vulnerability
400Amano et al. (28) have reported that IGT and DM
are independent predictors of lipid-rich coronary
plaque and that increased HOMA-IR, a simple
index of insulin resistance, is associated with an
elevated lipid component. Thus, diabetic status,
hyperinsulinemia, and insulin resistance may be
related to the increased plaque vulnerability under-
lying the poor long-term outcomes in diabetic and
pre-diabetic patients.
On conventional IVUS analysis, EEM was sig-
nificantly increased with greater PM volume in
patients in the high tertile of hyperinsulinemia.
These findings suggested that coronary vessels in
patients with hyperinsulinemia might be compen-
satorily enlarged to prevent atheroma from en-
croaching on the lumen. On IB-IVUS analysis,
plaques in patients with hyperinsulinemia had a
significantly increased proportion of lipid area. Pre-
vious studies have reported that positively remod-
eled vessels with greater plaque volume (29) and
increased lipid-rich components (8,9) are relevant
to plaque vulnerability, resulting in increased coro-
nary events. Taken together, these findings might
explain how the development of atherosclerosis
contributes to increased plaque vulnerability in
patients with hyperinsulinemia.
The development of hyperinsulinemia, a measure
of insulin resistance, is associated with the progres-
sion of metabolic syndrome and DM (30), both of
which are associated with coronary atherosclerosis.
Moreover, hyperinsulinemia and insulin resistance
probably have several atherogenic effects, including
the promotion of inflammation and endothelial
dysfunction (31). In addition, accumulating evi-
dence from experimental studies has indicated that
insulin in physiological concentrations stimulates
cholesterol synthesis and low-density lipoprotein
binding in arterial smooth muscle cells in animal
models (32,33). Krone et al. (34) have demon-
strated that insulin stimulates the specific binding,
accumulation, and degradation of low-density
lipoprotein in human mononuclear leukocytes.
These findings provide evidence supporting a
direct role of insulin in the development of
lipid-rich atherosclerosis. Nevertheless, whether
or not insulin has direct atherogenic effects re-
mains controversial. Shamir et al. (35) demon-
strated that insulin administration in apolipopro-
tein E-null mice suppresses cholesterol synthesis,oxide production by macrophages, and decreases
the severity and extent of atherosclerotic plaques.
Dandona et al. (36) have shown in obese subjects
with IGT that vascular endothelial growth factor,
which accelerates the progression of atheroscle-
rosis, is suppressed by insulin. Our results suggest
that hyperinsulinemia is associated with lipid-
rich plaque and greater plaque burden, which may
lead to increased plaque vulnerability. However,
whether insulin increases lipid component and
plaque burden remains to be established.
Study limitations. First, lipid-rich plaque as defined
in the present study might not be a major marker of
plaque vulnerability. Although previous studies
have reported that vulnerable plaques in patients
with ACS are related to an increased percentage
lipid area (6–9), large, long-term studies are needed
to precisely define the value of lipid-rich plaque for
predicting future coronary events. Second, we ex-
cluded patients with DM. Insulin response to a
glucose load might differ in patients with DM
because of their impaired insulin secretion. Further
studies in patients with DM are required to assess
the relation between hyperinsulinemia and plaque
components. Third, AUC insulin in this study was
provided by only 3 measurements. It may be pref-
erable to calculate AUC insulin from several mea-
surements to evaluate it more accurately. Finally, we
did not perform 3-vessel IVUS in this study because
it is generally considered unacceptable to perform
IVUS interrogations of nonculprit vessels in the
setting of ACS. However, similar findings were
obtained when we evaluated whole coronary vessels
prior to PCI by IB-IVUS analysis.
C O N C L U S I O N S
Hyperinsulinemia was associated with an increased
lipid content and a greater plaque volume of non-
culprit intermediate lesions in nondiabetic patients
with ACS. Our findings suggest that the evaluation
of hyperinsulinemia may help identify patients at
higher risk and may assist us in making decisions
for prevention and treatment in this population.
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